All Stories

  1. Tricuspid regurgitation, right ventricular function, and renal congestion: a cardiorenal triangle
  2. Practical implementation and clinical benefits of the new automated dialysate sodium control biosensor
  3. Impact of Acetate versus Citrate Dialysates on Intermediary Metabolism—A Targeted Metabolomics Approach
  4. Creatine Kinase Elevation in Autosomal Dominant Polycystic Kidney Disease Patients on Tolvaptan Treatment
  5. Comparison of four medium cut-off dialyzers
  6. Tailoring the dialysate bicarbonate eliminates pre-dialysis acidosis and post-dialysis alkalosis
  7. Humoral Response after Three Doses of mRNA-1273 or BNT162b2 SARS-CoV-2 Vaccines in Hemodialysis Patients
  8. Cloudy fluid, cloudy diagnosis
  9. Antiphospholipase A2 receptor antibody-positive membranous nephropathy in the kidney donor: Lessons from a serendipitous transplantation
  10. Antibody maintenance and breakthrough infections 6 months after complete COVID-19 vaccination with the mRNA-1273 and BNT162b2 vaccines in hemodialysis patients
  11. Acute hepatitis post arteriovenous graft thrombectomy of hemodialysis vascular access
  12. Weekly seroconversion rate of the mRNA-1273 SARS-CoV-2 vaccine in haemodialysis patients
  13. Efficacy and safety of the Clearum dialyzer
  14. Fatal SARS-CoV-2 reinfection in an immunosuppressed patient on hemodialysis
  15. Rapid re‐transplantation safety following early kidney graft loss
  16. Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients
  17. Accelerated cellular rejection with prominent interstitial hemorrhage following cemiplimab treatment: How can we approach a renal transplant recipient under anti-PD1 therapy?
  18. Evaluation and comparison of polysulfone TS‐UL and PMMA NF‐U dialyzers versus expanded hemodialysis and postdilution hemodiafiltration
  19. Humoral response of mRNA-1273 SARS-CoV-2 vaccine in peritoneal dialysis patients
  20. A case of recurrent anemia due to chronic parvovirus B19 infection in a kidney transplant recipient. Can everolimus make a difference?
  21. SARS-CoV-2 Infection in a Spanish Cohort of CKD-5D Patients: Prevalence, Clinical Presentation, Outcomes, and De-Isolation Results
  22. Prevalence of COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening
  23. Living donor kidney transplantation is an effective option of renal replacement therapy in patients with light-chain amyloidosis (AL)
  24. Optimization of dialysate bicarbonate in patients treated with online haemodiafiltration
  25. Preliminary data on outcomes of SARS‐CoV‐2 infection in a Spanish single center cohort of kidney recipients
  26. Case report of COVID‐19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?
  27. Comparison of Solute Removal Properties Between High‐Efficient Dialysis Modalities in Low Blood Flow Rate